Measles outbreak in Dublin, 2000

Pediatric Infectious Disease Journal

Volumn 22, Issue 7, 2003, Pages 580-584

  McBrien, Jacqueline ^a,d   Murphy, John ^a   Gill, Denis ^a,c   Cronin, Mary ^b   O'Donovan, Catherine ^a   Cafferkey, Mary T ^a,c  

^a CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^b HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d NONE   (Ireland)

Author keywords

Children; Clinical presentation; Epidemiology; Measles; Outbreak

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; CHILD; CHILD HOSPITALIZATION; DEHYDRATION; EPIDEMIC; FEMALE; HEALTH PROMOTION; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; IMMUNIZATION; INFANT; INFECTION CONTROL; INTENSIVE CARE UNIT; IRELAND; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; PNEUMONIA; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; TREATMENT INDICATION;

EID: 0041461854     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000073059.57867.36     Document Type: Article

References (22)

1. World Health Assembly. Executive summary: resolution of the 42nd World Health Assembly (resolution WHA 42.32). Geneva: World Health Organization, 1989.
2. Vitek CR, Aduddell M, Brinton MJ, Hoffman RE, Redd SC. Increased protection during a measles outbreak of children previously vaccinated with a second dose of MMR vaccine. Pediatr Infect Dis J 1999;18:620-3.
3. CDC. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC. MMWR 1997;46(RR-11);1-20.
4. CDC. Measles: United States, 1999. MMWR 2000;49:557-60.
5. CDC. Global measles control and regional elimination, 1998-1999. JAMA 2000;283:472-4.
6. CDC. Measles outbreak: Netherlands, April 1999-January 2000. JAMA 2000;283:2385-6.
7. Papania M, Baughman AL, Lee S, Cheek JE, et al. Increased susceptibility to measles in infants in the United States. Pediatrics 1999;104:e59.
8. de Serres G, Boulianne N, Ratnam S, Corriveau A. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles. Pediatrics 1996;97:232-5.
9. Heap BJ. Notifiable diseases: too many doctors know too little about the topic. BMJ 1992;304:726-7.
10. Harrington PM, Woodman C, Shannon WF. Apparent low immunisation uptake in Dublin: under-performance or under-recording? Ir Med J 2000;93:239-40.
11. Wakefield AJ, Murch SH, Linnell AAJ, Casson DM, Malik M, Berelowitz M. Ileal-lymphoid-nodular hyperplasia, non-specific colitis and pervasive developmental disorder in children. Lancet 1998;351:637-41.
12. Wakefield AJ, Montgomery SM. Mumps measles rubella vaccine: through a glass darkly. Adverse Drug Reaction Toxicol Rev 2000;19:265-83.
13. Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine: a double-blind placebo-controlled trial in twins. Lancet 1986;1:939-42.
14. Taylor BME, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J, Waight PA. Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026-9.
15. Elliman D, Bedford H. MMR vaccine: the continuing saga. BMJ 2000;322:183-4.
16. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998 May 2;351:1327-8.
17. Jatja A, Davidkin I, Kurki T, Kallio MJT, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J 2000;19:1127-34.
18. Taylor B, Miller E, Lingham R, Andrews N, Simmons A, Stowe J. Measles, mumps and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 2002;324:393-6.
19. Fitzgerald M, O'Flanagan D. Immunisation uptake statistics for Ireland, Quarter 4, 2001: a report by The National Disease Surveillance Centre (online), 2001. Available from: http://www.ndsc.ie/Publications/ImmunisationUptakeStatistics/d330.PDF.
20. Coughlan S, Connell J, Cohen B Jin L Hall W. Suboptimal measles-mumps-rubella vaccination coverage facilitates an imported measles outbreak in Ireland. Clin Infect Dis 2002;35:84-6.
21. The MMR discussion pack: an information guide for health professionals and parents. The Health Boards Executive 2002 (www.hebe.ie) ISBN 0 9542449 1 5.
22. MMR frequently asked questions. National Immunisation Advisory Committee, Royal College of Physicians of Ireland. Dublin: National Disease Surveillance Centre, 2002. E-mail karendoyle@rcpi.ie.